The cold reality is successful outcomes in mice means nothing for humans. Lots of successful experiments on mice have failed miserably in human trials. Secondly immunotherapy for pancreatic cancers has fared poorly because it’s hard for the T cells to penetrate the tumor microenvironment. How are they going to get around that ? Maybe they have found a way.
For that matter, look at post #4’s studies and simple things to try.
.....Secondly immunotherapy for pancreatic cancers has fared poorly because it’s hard for the T cells to penetrate the tumor microenvironment.....
Well, that’s part of what they’re trying to overcome.
Nevertheless, it’s still only in mice, albeit with a transplanted human tumor.